Allmed Medical Products Co Ltd Class A
Allmed Medical Products Co., Ltd manufactures and sells wound care and nursing material products in China. The company's traditional wound care products include non-woven and woven gauze swabs, non-adherent pads, drain sponges, abdominal pads, fluffy sponges/bandages, woven gauze and nonwoven gauze balls, eye pads, cotton-filled exodontia sponges, packing strips, ribbon gauze, cotton-tipped appli… Read more
Allmed Medical Products Co Ltd Class A (002950) - Total Liabilities
Latest total liabilities as of September 2025: CN¥1.60 Billion CNY
Based on the latest financial reports, Allmed Medical Products Co Ltd Class A (002950) has total liabilities worth CN¥1.60 Billion CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Allmed Medical Products Co Ltd Class A - Total Liabilities Trend (2014–2024)
This chart illustrates how Allmed Medical Products Co Ltd Class A's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Allmed Medical Products Co Ltd Class A Competitors by Total Liabilities
The table below lists competitors of Allmed Medical Products Co Ltd Class A ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
ioneer Ltd American Depositary Shares
NASDAQ:IONR
|
USA | $3.24 Million |
|
Tectonic Therapeutic, Inc.
NASDAQ:TECX
|
USA | $9.71 Million |
|
Nanfang Black Sesame Group Co Ltd
SHE:000716
|
China | CN¥1.87 Billion |
|
Beijing Shengtong Printing Co Ltd
SHE:002599
|
China | CN¥897.77 Million |
|
CICOR TECHNOL.NAM. SF 10
F:CRLN
|
Germany | €347.12 Million |
|
Nu Skin Enterprises Inc
NYSE:NUS
|
USA | $624.61 Million |
|
Maxvision Technology Corp
SHE:002990
|
China | CN¥1.30 Billion |
Liability Composition Analysis (2014–2024)
This chart breaks down Allmed Medical Products Co Ltd Class A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.00 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.43 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.30 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Allmed Medical Products Co Ltd Class A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Allmed Medical Products Co Ltd Class A (2014–2024)
The table below shows the annual total liabilities of Allmed Medical Products Co Ltd Class A from 2014 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥1.61 Billion | -14.01% |
| 2023-12-31 | CN¥1.87 Billion | -28.40% |
| 2022-12-31 | CN¥2.62 Billion | +16.15% |
| 2021-12-31 | CN¥2.25 Billion | +16.55% |
| 2020-12-31 | CN¥1.93 Billion | +76.28% |
| 2019-12-31 | CN¥1.10 Billion | -30.53% |
| 2018-12-31 | CN¥1.58 Billion | +34.45% |
| 2017-12-31 | CN¥1.17 Billion | +33.55% |
| 2016-12-31 | CN¥879.11 Million | +2.94% |
| 2015-12-31 | CN¥854.02 Million | -15.35% |
| 2014-12-31 | CN¥1.01 Billion | -- |